The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of inflammatory biomarkers from peripheral blood and clinical factors in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with radium-223 (Ra-223) (BIO-Ra-223 study).
 
Sara Elena Rebuzzi
No Relationships to Disclose
 
Matteo Bauckneht
No Relationships to Disclose
 
Alessio Signori
No Relationships to Disclose
 
Viviana Frantellizzi
No Relationships to Disclose
 
Elisa Lodi Rizzini
No Relationships to Disclose
 
Manlio Mascia
No Relationships to Disclose
 
Valentina Lavelli
No Relationships to Disclose
 
Maria Lina Stazza
No Relationships to Disclose
 
Maria Licari
No Relationships to Disclose
 
Maria Isabella Donegani
No Relationships to Disclose
 
Marta Ponzano
No Relationships to Disclose
 
Letizia Cavallini
No Relationships to Disclose
 
Viola Laghi
No Relationships to Disclose
 
Luca Cindolo
No Relationships to Disclose
 
Renato Patrizio Costa
No Relationships to Disclose
 
Angela Spanu
No Relationships to Disclose
 
Giuseppe Rubini
No Relationships to Disclose
 
Fabio Monari
No Relationships to Disclose
 
Giuseppe De Vincentis
No Relationships to Disclose
 
Giuseppe Fornarini
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen